OTTAWA—Health Canada has approved the use of remdesivir to treat patients with severe symptoms of COVID-19.
The federal agency says the antiviral drug may be used to treat patients who have pneumonia and require extra oxygen to help them breathe.
Vials of investigational COVID-19 treatment drug remdesivir are capped at a Gilead Sciences facility in La Verne, Calif., on March 18, 2020. Gilead Sciences via Reuters
|Updated:
